Higher high-sensitivity cardiac troponin T is linked with mortality in human cohorts, while a cohort study links it with cognitive decline. Older age and impaired kidney function are linked with higher levels. A trial in previously sedentary older adults reports that exercise attenuates its rise over a year.
39 findings in 24 papers from 2016 to 2026, 8 of them since September 2026
“we observed hs-cTnT concentrations being significantly associated with sex, age, eGFR and CVD in uni- and multivariable analyses”
Moderate-to-vigorous physical activity is linked with lower high-sensitivity cardiac troponin T in humans (less active men with subclinical cardiac damage; per 30 min/day increment) (MPD -13.1 (95% CI -18.3, -7.5)).
Humansless active men with subclinical cardiac damage; per 30 min/day increment30 min/day moremales
High-sensitivity cardiac troponin T is linked with better discrimination of all-cause mortality risk in humans (Compared with high-sensitivity cardiac troponin I) (AUC 0.795 versus 0.719 at 1 year; 0.742 versus 0.703 at 5 years).
HumansCompared with high-sensitivity cardiac troponin INext-generation assay (6th Generation)1 and 5 years48.9% femalesn = 14,361
High-sensitivity cardiac troponin T is associated with cardiovascular disease in humans (Dallas Heart Study; per 1-SD increase in log hs-cTnT) (HR 1.27, 95% CI 1.15–1.32 per 1-SD increase in log hs-cTnT).
ReviewDallas Heart Study; per 1-SD increase in log hs-cTnTn = 3,276
Estimated glomerular filtration rate is associated with high-sensitivity cardiac troponin T in humans (Multivariable analysis in the general population).
HumansMultivariable analysis in the general populationn = 15,351
Estimated glomerular filtration rate is associated with high-sensitivity cardiac troponin T in humans (Chest pain without myocardial infarction; reduced estimated glomerular filtration rate).
Quadriceps muscle strength is associated with high-sensitivity cardiac troponin T in humans (Without overt cardiovascular disease; fully adjusted analysis) (6.3% lower hs-cTnT per 1-SD increase in strength; β −0.065, 95% CI −0.090 to −0.040).
High-sensitivity cardiac troponin T is associated with cardiovascular disease risk in humans (Primary prevention populations) (Risk inflection point at approximately 4 ng/L).
High-sensitivity cardiac troponin T is associated with cardiovascular disease events in humans (Type 2 diabetes, irrespective of chronic kidney disease status).
Female sex is associated with high-sensitivity cardiac troponin T in humans (general population) (Median 5 ng/L in women versus 9 ng/L in men; p<0.001).
Humansgeneral population6th generation assaybloodwomen versus mensn = 15,351
In the high-score group, intensive versus standard control reduced cardiovascular risk; the adjusted hazard ratio, comparing event rates over time, was 0.64.In the high-score group, intensive versus standard control reduced cardiovascular risk; the adjusted hazard ratio, comparing event rates over time, was 0.64.
A post-hoc analysis of 3,775 trial participants linked two heart markers to cardiovascular events, whether or not participants had chronic kidney disease.A post-hoc analysis of 3,775 trial participants linked two heart markers to cardiovascular events, whether or not participants had chronic kidney disease.
In 14,361 adults followed for 4.4 years, a next-generation test for a heart-damage protein predicted deaths and cardiovascular events better than an established test.In 14,361 adults followed for 4.4 years, a next-generation test for a heart-damage protein predicted deaths and cardiovascular events better than an established test.